Table 5.
Comorbidity | Age at Diagnosis (years) |
P | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
15-19 |
20-24 |
25-29 |
30-34 |
35-39 |
|||||||
No. | Wt % | No. | Wt % | No. | Wt % | No. | Wt % | No. | Wt % | ||
Any comorbidity | 72 | 25.7 | 82 | 22.8 | 68 | 24.3 | 107 | 31.8 | 96 | 39.9 | < .001 |
Asthma | 5.8 | 6.2 | 3.8 | 4.3 | 3.8 | ||||||
Cardiovascular | 1.7 | 1 | 1.9 | 5.9 | 2.5 | ||||||
Cerebral vascular accident | 0.2 | 0.3 | 0.1 | 0 | 0 | ||||||
Diabetes | 0.9 | 1.6 | 1.1 | 4.6 | 3.1 | ||||||
Endocrine | 0.6 | 1 | 4.5 | 1.4 | 4 | ||||||
GI | 1.5 | 2.1 | 1.9 | 6.4 | 2.5 | ||||||
HIV/AIDS | 0.3 | 0.5 | 0.1 | 2.9 | 6.8 | ||||||
Hematologic | 1 | 0.3 | 0.9 | 1.3 | 2.6 | ||||||
Hypertension | 2.6 | 1.6 | 4.6 | 7 | 7.4 | ||||||
Liver | 0.6 | 2.8 | 2.5 | 0.4 | 2.3 | ||||||
Life-threatening infection | 1.4 | 0 | 0 | 0.1 | 0 | ||||||
Mental health | 7.3 | 5.6 | 6.8 | 4.8 | 11.3 | ||||||
Neurologic | 3.1 | 4.1 | 4.2 | 1.4 | 4.1 | ||||||
Obesity/overweight | 6.3 | 2.3 | 2.6 | 2.9 | 1.8 | ||||||
Renal | 1.2 | 0.6 | 0.3 | 0.9 | 2.4 | ||||||
Rheumatologic/autoimmune | 0.2 | 0.7 | 0.1 | 3.5 | 2 | ||||||
Cancer Type |
P | ||||||||||
NHL |
HL |
ALL |
Germ Cell |
Sarcoma |
|||||||
No. | Wt % | No. | Wt % | No. | Wt % | No. | Wt % | No. | Wt % | ||
Any comorbidity | 119 | 38.0 | 111 | 33.0 | 78 | 40.0 | 74 | 20.4 | 43 | 25.7 | < .001 |
Race/Ethnicity |
P | ||||||||||
Non-Hispanic White |
Non-Hispanic Black |
Hispanic |
Asian/Pacific Islander |
American Indian/Alaska Native |
|||||||
No. | Wt % | No. | Wt % | No. | Wt % | No. | Wt % | No. | Wt % | ||
Any comorbidity | 202 | 31.3 | 90 | 43.4 | 94 | 20.8 | 32 | 23.1 | 7 | 53.6 | < .001 |
Abbreviations: ALL, acute lymphoblastic leukemia; HL, Hodgkin's lymphoma; NHL, Non-Hodgkin's lymphoma; Wt, weighted.